These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
546 related items for PubMed ID: 10464631
1. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Ganguly A, Leahy K, Marshall AM, Dhulipala R, Godmilow L, Ganguly T. Genet Test; 1997; 1(2):85-90. PubMed ID: 10464631 [Abstract] [Full Text] [Related]
2. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Roa BB, Boyd AA, Volcik K, Richards CS. Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191 [Abstract] [Full Text] [Related]
3. Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, Haas B, Osborne M, Norton L, Gilbert F, Offit K. Genet Test; 1997 Oct; 1(1):47-51. PubMed ID: 10464625 [Abstract] [Full Text] [Related]
4. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192 [Abstract] [Full Text] [Related]
5. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E. Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978 [Abstract] [Full Text] [Related]
6. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer. Schubert EL, Mefford HC, Dann JL, Argonza RH, Hull J, King MC. Genet Test; 1997 Dec; 1(1):41-6. PubMed ID: 10464624 [Abstract] [Full Text] [Related]
7. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K. Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092 [Abstract] [Full Text] [Related]
8. An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews. Lalloo F, Cochrane S, Bulman B, Varley J, Elles R, Howell A, Evans DG. J Med Genet; 1998 Jan; 35(1):10-2. PubMed ID: 9475087 [Abstract] [Full Text] [Related]
9. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA. Am J Hum Genet; 2000 Apr; 66(4):1259-72. PubMed ID: 10739756 [Abstract] [Full Text] [Related]
10. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D. Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153 [Abstract] [Full Text] [Related]
11. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, Kant R, Gupta V, Shukla NK, Deo SS, Das BC. Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800 [Abstract] [Full Text] [Related]
12. The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, Zehavi M, Sidi AA, Ramon Y, Tischler T, Livne PM, Friedman E. Br J Cancer; 2000 Aug; 83(4):463-6. PubMed ID: 10945492 [Abstract] [Full Text] [Related]
14. BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer. Gershoni-Baruch R, Dagan E, Fried G, Kepten I, Robinson E. Eur J Hum Genet; 1999 Aug; 7(7):833-6. PubMed ID: 10573018 [Abstract] [Full Text] [Related]
15. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. J Clin Oncol; 2002 Feb 15; 20(4):994-9. PubMed ID: 11844822 [Abstract] [Full Text] [Related]
16. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer. Kreiss Y, Barak F, Baruch RG, Levy-Lahad E, Pras E, Friedman E. Genet Test; 2000 Feb 15; 4(4):403-7. PubMed ID: 11216667 [Abstract] [Full Text] [Related]
17. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer. Steinmann D, Bremer M, Rades D, Skawran B, Siebrands C, Karstens JH, Dörk T. Br J Cancer; 2001 Sep 14; 85(6):850-8. PubMed ID: 11556836 [Abstract] [Full Text] [Related]
18. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK. Cancer Res; 1996 Aug 01; 56(15):3409-14. PubMed ID: 8758903 [Abstract] [Full Text] [Related]
19. Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer. Lehrer S, Fodor F, Stock RG, Stone NN, Eng C, Song HK, McGovern M. Br J Cancer; 1998 Sep 01; 78(6):771-3. PubMed ID: 9743298 [Abstract] [Full Text] [Related]
20. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K. Clin Cancer Res; 2002 Dec 01; 8(12):3776-81. PubMed ID: 12473589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]